metformin has been researched along with Port-Wine Stain in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Port-Wine Stain: A vascular malformation of developmental origin characterized pathologically by ectasia of superficial dermal capillaries, and clinically by persistent macular erythema. In the past, port wine stains have frequently been termed capillary hemangiomas, which they are not; unfortunately this confusing practice persists: HEMANGIOMA, CAPILLARY is neoplastic, a port-wine stain is non-neoplastic. Port-wine stains vary in color from fairly pale pink to deep red or purple and in size from a few millimeters to many centimeters in diameter. The face is the most frequently affected site and they are most often unilateral. (From Rook et al., Textbook of Dermatology, 5th ed, p483)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, M | 1 |
| Lin, Y | 1 |
| Shi, W | 1 |
| Chen, X | 1 |
| Mi, Z | 1 |
| Jia, Z | 1 |
| Pan, Q | 1 |
| Wang, Z | 1 |
| Han, J | 1 |
| Liu, H | 1 |
1 other study available for metformin and Port-Wine Stain
| Article | Year |
|---|---|
Topical metformin suppresses angiogenesis pathways induced by pulsed dye laser irradiation in animal models.
Topics: Administration, Cutaneous; Animals; Lasers, Dye; Metformin; Models, Animal; Neovascularization, Path | 2022 |